Prognostic DNA methylation biomarkers in ovarian cancer

Clinical Cancer Research

Volumn 12, Issue 9, 2006, Pages 2788-2794

  Wei, Susan H ^a,j   Balch, Curtis ^c,h   Paik, Henry H ^c   Kim, Yoo Sung ^c,e   Baldwin, Rae Lynn ^f   Liyanarachchi, Sandya ^a   Li, Lang ^g   Wang, Zailong ^b   Wan, Joseph C ^a   Davuluri, Ramana V ^a   Karlan, Beth Y ^f   Gifford, Gillian ⁱ   Brown, Robert ⁱ   Kim, Sun ^d   Huang, Tim H M ^a   Nephew, Kenneth P ^c,h,k  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c Indiana University School of Medicine   (United States)

^d INDIANA UNIVERSITY   (United States)

^e Inha University   (South Korea)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF GLASGOW   (United Kingdom)

^j CEDARS SINAI MEDICAL CENTER   (United States)

^k INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ALGORITHM; ARTICLE; BIOINFORMATICS; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; DNA METHYLATION; FEMALE; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; CHROMOSOME MAPPING; DNA METHYLATION; FEMALE; HUMANS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 33646725688     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-1551     Document Type: Article

References (34)

1. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004;429:457-63.
2. Bastian PJ, Ellinger J, Schmidt D, et al. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age? Eur J Med Res 2004;9:523-7.
3. Henrique R, Jeronimo C. Molecular detection of prostate cancer: a role for GSTP1 hypermethylation. Eur Urol 2004;46:660-9.
4. House MG, Herman JG, Guo MZ, et al. Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms. Ann Surg 2003;238:423-32.
5. Yang B, Guo M, Herman JG, Clark DP. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 2003;163:1101-7.
6. House MG, Guo M, Efron DT, et al. Tumor suppressor gene hypermethylation as a predictor of gastric stromal tumor behavior. J Gastrointest Surg 2003;7:1004-14.
7. Wei SH, Chen CM, Strathdee G, et al. Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers. Clin Cancer Res 2002;8:2246-52.
8. Costello JF, Fruhwald MC, Smiraglia DJ, et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 2000;24:132-8.
9. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A 2002;99:6567-72.
10. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001;98:5116-21.
11. Yan PS, Chen CM, Shi H, et al. Applications of CpG island microarrays for high-throughput analysis of DNA methylation. J Nutr 2002;132:2430-4S.
12. Thomas JG, Olson JM, Tapscott SJ, Zhao LP. An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles. Genome Res 2001;11:1227-36.
13. Witten IH, Frank E. Data mining: practical machine learning tools and techniques with Java implementations. San Francisco (California): Morgan Kaufmann; 1999.
14. Cristianini N, Shawe-Taylor J. An introduction to Support Vector Machines and other kernel-based learning methods. New York: Cambridge University Press; 2000.
15. Schölkopf B, Warmuth ME, editors. Computational learning theory and kernel machines: 16th Annual Conference on Computational Learning Theory and 7th Kernel Workshop. COLT/Kernel 2003: Proceedings. Lecture Notes in Computer Science. Washington, DC, USA, 2003 August 24-27. New York Springer; 2003.
16. Storey JD. A direct approach to false discovery rates. J R Stat Soc Ser B 2002;64:479-98.
17. Shao J, Tu D. The jackknife and bootstrap. New York: Springer Verlag; 1995.
18. Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 2005;11:845-56.
19. Ushijima T. Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 2005;5:223-31.
20. Cottrell SE, Laird PW. Sensitive detection of DNA methylation. Ann N Y Acad Sci 2003;983:120-30.
21. Li LC, Carroll PR, Dahiya R. Epigenetic changes in prostate cancer: implication for diagnosis and treatment. J Natl Cancer Inst 2005;97:103-15.
22. Bae YK, Brown A, Garrett E, et al. Hypermethylation in histologically distinct classes of breast cancer. Clin Cancer Res 2004;10:5998-6005.
23. Zochbauer-Muller S, Minna JD, Gazdar AF. Aberrant DNA methylation in lung cancer: biological and clinical implications. Oncologist 2002;7:451-7.
24. Yang Q, Zage P, Kagan D, et al. Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma. Clin Cancer Res 2004;10:8493-500.
25. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001;61:3225-9.
26. Spentzos D, Levine DA, Ramoni MF, et al. Gene expression signature with independent prognostic significance in epithelial ovarian cancer. J Clin Oncol 2004;22:4700-10.
27. Glinsky GV, Berezovska O, Glinskii AB. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 2005;115:1503-21.
28. Laird PW. The power and the promise of DNA methylation markers. Nat Rev Cancer 2003;3:253-66.
29. Motiwala T, Ghoshal K, Das A, et al. Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas. Oncogene 2003;22:6319-31.
30. Wimmer K, Zhu X-x, Rouillard JM, et al. Combined restriction landmark genomic scanning and virtual genome scans identify a novel human homeobox gene, ALX3, that is hypermethylated in neuroblastoma. Genes Chromosomes Cancer 2002;33:285-94.
31. Iliopoulos D, Guler G, Han SY, et al. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Oncogene 2005;24:1625-33.
32. Gourley C, Paige AJ, Taylor KJ, et al. WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclear. Int J Oncol 2005;26:1681-9.
33. Jeney V, Itoh S, Wendt M, et al. Role of antioxidant-1 in extracellular superoxide dismutase function and expression. Circ Res 2005;96:723-9.
34. Mates JM, Sanchez-Jimenez F. Antioxidant enzymes and their implications in pathophysiologic processes. Front Biosci 1999;4:D339-45.